Related Experiment Video
Updated: Jul 14, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients
Constance Delaugerre1, Dominique Mathez, Gilles Peytavin
1Department of Virology, Ambroise Pare Hospital, APHP, Boulogne, France.
Abstract:
In highly experienced HIV-1-infected patients, a ritonavir-boosted darunavir-containing regimen was associated with dramatic immunological and virological efficacy. Patients harbouring viruses with amprenavir-specific resistance profiles, such as I50V or V32I + I47V, failed on a darunavir/ritonavir-containing regimen. These key amprenavir mutations were also selected at the time of failure, suggesting their impact on darunavir efficacy.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion
Viral Mutations
Inhibitors of Viral Protein Synthesis
Retroviruses

